Surprisingly, SETD1B expression was most significantly elevated in hepatocellular carcinoma (HCC, referred to as LIHC in TCGA) and cholangiocarcinoma (CHOL) (Figure 1A; Figure S1A-C). The gene discussed is SETD1B; the disease is cholangiocarcinoma.